UnitedHealth Group Incorporated (NYSE:UNH) Stake Raised by Act Two Investors LLC

Act Two Investors LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 56,768 shares of the healthcare conglomerate’s stock after acquiring an additional 2,609 shares during the period. UnitedHealth Group makes up 6.5% of Act Two Investors LLC’s portfolio, making the stock its 5th biggest position. Act Two Investors LLC’s holdings in UnitedHealth Group were worth $29,887,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently modified their holdings of the stock. Verdence Capital Advisors LLC boosted its position in shares of UnitedHealth Group by 2.1% during the fourth quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock valued at $8,919,000 after buying an additional 342 shares during the last quarter. Ascension Capital Advisors Inc. bought a new position in UnitedHealth Group in the third quarter valued at about $216,000. Bellecapital International Ltd. lifted its holdings in UnitedHealth Group by 1.4% in the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock valued at $7,277,000 after acquiring an additional 193 shares during the period. Great Valley Advisor Group Inc. lifted its holdings in UnitedHealth Group by 5.8% in the third quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock valued at $17,292,000 after acquiring an additional 1,884 shares during the period. Finally, Rise Advisors LLC lifted its holdings in UnitedHealth Group by 326.0% in the fourth quarter. Rise Advisors LLC now owns 213 shares of the healthcare conglomerate’s stock valued at $112,000 after acquiring an additional 163 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent research reports. Bank of America reissued a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a report on Monday, April 8th. TD Cowen decreased their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Truist Financial reaffirmed a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Three investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Price Performance

NYSE UNH traded down $8.66 during trading on Friday, hitting $508.17. 2,528,228 shares of the stock traded hands, compared to its average volume of 2,805,318. The company has a market capitalization of $467.71 billion, a P/E ratio of 31.06, a price-to-earnings-growth ratio of 1.47 and a beta of 0.55. The firm has a 50-day simple moving average of $489.23 and a 200-day simple moving average of $510.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter last year, the business posted $6.26 EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.